New and Updated Clinical Influenza Vaccine Trials
-
Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
Nov 15, 2019 | 18:00 pmCondition: InfluenzaIntervention: Drug: Flumist Quadrivalent Nasal ProductSponsor: University of Alabama at BirminghamNot yet recruiting
-
Test-and-treat for Influenza in Homeless Shelters
Oct 28, 2019 | 17:00 pmConditions: Influenza; Respiratory Viral InfectionIntervention: Combination Product: Point-of-care molecular testing and treatment of influenzaSponsors: University of Washington; Genentech, Inc.Recruiting
-
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Oct 1, 2019 | 18:00 pmConditions: Influenza; Vaccine Virus SheddingIntervention: Biological: Live attenuated influenza vaccineSponsor: Imperial College Healthcare NHS TrustActive, not recruiting
-
Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients
Oct 1, 2019 | 18:00 pmCondition: InfluenzaIntervention: Sponsor: University Hospital, Strasbourg, FranceNot yet recruiting
-
The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets
Apr 2, 2019 | 18:00 pmCondition: InfluenzaInterventions: Biological: Live attenuated influenza vaccine (LAIV4); Biological: Inactivated Influenza Vaccine (IIV4)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting
-
Response to Influenza Vaccine During Pregnancy
Mar 25, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response
Oct 9, 2018 | 18:00 pmCondition: Influenza A Subtype H5N1 InfectionIntervention: Biological: Seasonal Influenza VaccineSponsors: Emory University; National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Reducing the Burden of Influenza After Solid-Organ Transplantation
Oct 9, 2018 | 18:00 pmConditions: Influenza; Organ TransplantationInterventions: Biological: High-dose influenza vaccine; Biological: MF59-adjuvanted influenza vaccine; Biological: Standard intramuscular influenza vaccineSponsors: Oriol Manuel; University Hospital, Basel, Switzerland; University of Bern; University Hospital, Geneva; University of Zurich; Cantonal Hospital of St. Gallen; Fondazione Epatocentro TicinoRecruiting
-
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
Sep 27, 2018 | 18:00 pmCondition: InfluenzaIntervention: Biological: Seasonal influenza vaccineSponsor: Emory UniversityRecruiting
-
Influenza Vaccine Responses
Jul 27, 2018 | 18:00 pmCondition: InfluenzaInterventions: Drug: Fluad Vaccine; Drug: Fluzone High-DoseSponsors: Mayo Clinic; National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting
-
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Jun 28, 2018 | 18:00 pmCondition: Human InfluenzaIntervention: Biological: influenza vaccineSponsors: Research Institute for Biological Safety Problems; Asfendiyarov Kazakh National Medical University; Research Institute of Influenza, RussiaCompleted
-
Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)
Jun 6, 2018 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent Influenza VaccineSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
QuickVue Influenza A + B Test Field Study
Jan 31, 2018 | 18:00 pmCondition: Influenza A, Influenza BIntervention: Device: QuickVue Influenza A+BSponsor: Quidel CorporationCompleted
-
Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
Jan 5, 2018 | 18:00 pmCondition: InfluenzaInterventions: Biological: Multi-dose Quadrivalent Influenza Vaccine; Biological: Single-dose Quadrivalent Influenza VaccineSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Improved Novel VaccIne CombinaTion InflUenza Study
Oct 3, 2017 | 18:00 pmCondition: InfluenzaInterventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chlorideSponsors: Vaccitech Limited; University of OxfordTerminated
-
Immune Response Following Seasonal Influenza Vaccination
May 23, 2017 | 18:00 pmCondition: InfluenzaIntervention: Biological: Licensed seasonal influenza vaccineSponsors: Altimmune, Inc.; Optimal Health ResearchCompleted
-
School-located Influenza Vaccination Clinics for Adolescents
May 3, 2017 | 18:00 pmConditions: Childhood Influenza Vaccination; School-located Influenza VaccinationIntervention: Other: School-located Influenza VaccinationSponsors: University of California, Los Angeles; University of Rochester; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Feb 20, 2017 | 18:00 pmCondition: Influenza VaccinesIntervention: Biological: Seasonal Influenza vaccineSponsor: Butantan InstituteCompleted
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Sep 27, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent vaccine, No PreservativeSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
Jun 30, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza VaccineSponsor: Butantan InstituteCompleted